In Finnish population, apoE genotypes were found to modulate the risk of coronary heart disease (CHD) and atherosclerotic vascular disease in non-insulin dependent diabetes mellitus (NIDDM) [20, 21]. This evidence concerns the gene APOE and type 2 diabetes mellitus.